by McKesson Ventures | Jul 27, 2017 | Portfolio News
Amazon has started a skunkworks lab headquartered in the company’s Seattle home base to work on healthcare technology innovations. Dubbed 1492, the lab is focusing on both hardware and software projects, including pulling data from existing electronic medical records...
by McKesson Ventures | Jul 27, 2017 | Portfolio News
In March 2017, Amazon invested in GRAIL, a health startup that is researching deep sequencing technology to discover early signs of cancer in the blood. At the time, it was unclear as to why Amazon would be interested in a company like this, given the fact that the...
by McKesson Ventures | Jul 27, 2017 | Portfolio News
Verily, Alphabet’s life sciences spinoff, has invested in Bay Area biotech startup Freenome in a $65 million Series A round. Freenome’s work revolves around detecting early-stage cancer. As part of the investment, Verily constructed a new lab for the company....
by McKesson Ventures | Jul 26, 2017 | Portfolio News
In a recent article for the Financial Times, David Crow details how cancer has deeply affected his family: five family members, including his mother, have died of cancer. Hereditary cancer tests like those offered by Myriad Genetics make it possible for individuals...
by McKesson Ventures | Jun 5, 2017 | Press Releases
GRAIL, Inc., a life sciences company whose mission is to detect cancer early when it can be cured, announced on May 31 that it has entered into a definitive agreement to combine with Cirina, Ltd., another company focused on early detection of cancer. The work of Hong...
